Screener
Ultragenyx Pharmaceutical RARE Invested capital
Discontinued — last reported Q4 '25
Invested capital at other companies
Other financials
Where this comes from
Calculated from Ultragenyx Pharmaceutical’s reported figures.
The source filing: Ultragenyx Pharmaceutical’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333233
FAQ
- What is Ultragenyx Pharmaceutical's invested capital?
- Ultragenyx Pharmaceutical (RARE) reported invested capital of -$465M in Q4 2025.
- How has Ultragenyx Pharmaceutical's invested capital changed year-over-year?
- Ultragenyx Pharmaceutical's invested capital decreased by 483.2% year-over-year, from $121.34M to -$465M.
- What is the long-term trend for Ultragenyx Pharmaceutical's invested capital?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's invested capital has grown at a -1.0% compound annual growth rate (CAGR), from $489.08M to -$465M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Ultragenyx Pharmaceutical's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude